Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/17/2018 01/18/2018 01/19/2018 01/22/2018 01/23/2018 Date
27.25(c) 27.4(c) 27.65(c) 27.61(c) 27.82(c) Last
5 864 654 6 942 018 10 024 428 6 030 292 5 563 654 Volume
+1.00% +0.55% +0.91% -0.14% +0.76% Change
More quotes
Financials ($)
Sales 2017 9 010 M
EBIT 2017 2 182 M
Net income 2017 981 M
Debt 2017 5 130 M
Yield 2017 -
Sales 2018 9 608 M
EBIT 2018 2 352 M
Net income 2018 1 308 M
Debt 2018 4 075 M
Yield 2018 -
P/E ratio 2017 35,63
P/E ratio 2018 27,99
EV / Sales2017 4,79x
EV / Sales2018 4,38x
Capitalization 38 051 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.Its products and technologies are used to diagnose or treat medical conditions, including heart, digestive, pulmonary, vascular, urological, women's... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
01/23 BOSTON SCIENTIFIC : 65-- 506q86978-icd procedure-boston scientific
01/23 BOSTON SCIENTIFIC : $10,773 Federal Contract Awarded to Boston Scientific
01/19 BOSTON SCIENTIFIC : Announces Updated Time For Webcast Conference Call Discussin..
01/19 BOSTON SCIENTIFIC : Receives U.S. FDA Approval for Spectra WaveWriter Spinal Cor..
01/19 BOSTON SCIENTIFIC : Reports from Monash Medical Center Provide New Insights into..
01/19 BOSTON SCIENTIFIC : Announces Positive Results from WHISPER Spinal Cord Stimulat..
01/17 ACCENTURE : Opens Innovation Hub in Boston; Plans to Add 400 Technology Jobs to ..
01/16 ACCENTURE : Opens Innovation Hub in Boston; Plans to Add 400 Technology Jobs to ..
01/16 BOSTON SCIENTIFIC CORPORATION : Blog Exposure - Boston Scientific’s Spectra Wave..
01/14 BOSTON SCIENTIFIC : Yale New Haven doctors use device to trap blood clots, preve..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/16 Siemens' Healthineers in pre-IPO cost-cutting drive
01/03 Akzo Nobel appoints Arcadis's Vree as CFO of chemicals business
2017 ROYAL PHILIPS : Philips Buys VitalHealth for Undisclosed Sum
2017 SAFRA CATZ : Oracle's Safra Catz among two new members named to Disney board
2017 ROYAL PHILIPS : Philips Buys Interoperability Provider Forcare for Undisclosed S..
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
BOSTON SCIENTIFIC CORPORATION - 2012
All technical elements to short
SELL
More Strategies
Latest Tweets
01/23Global Deep Brain Stimulation Devices Strategic Business Report 2018: Leading.. 
01/23Global Deep Brain Stimulation Devices Strategic Business Report 2018: Leading.. 
01/22New chief at Neovasc; shares up 19%  
01/22New chief at Neovasc  
01/22Neovasc Names Former BeneChill CEO as New Leader  
More tweets
Qtime:138
News from SeekingAlpha
01/16 Boston Scientific (BSX) Investor Update (North American Neuromodulation Socie..
01/13 YOUR DAILY PHARMA SCOOP : Lipocine's Gloomy Future, Puma Labeling Change, Concer..
01/12 YOUR DAILY PHARMA SCOOP : AbbVie Highlights Pipeline, Novavax Surges, Lipocine F..
01/11 FDA OKs Boston Scientific's Spectra WaveWriter SCS System
01/09 Boston Scientific (BSX) Presents At 36th Annual J.P. Morgan Healthcare Confer..
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 31,0 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Michael V. Chobotov Chairman & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION11.54%38 051
THERMO FISHER SCIENTIFIC12.44%85 889
DANAHER8.34%69 540
INTUITIVE SURGICAL18.91%48 622
ROYAL PHILIPS5.64%38 418
ILLUMINA11.47%35 798